Skip to content

Quantification Ladder

A four-tier framework for measuring compound or enzyme content. Use the lowest tier that satisfies the decision, anchored to a higher-rigor calibration for each protocol and material class.

Track-specific pages define assay chemistry, standards, sample preparation, and calibration anchors.

The four tiers

Tier Equipment ceiling Output type Use case
1. Kitchen Hand tools, eyes, kitchen scale, basic reagents (vinegar, milk, starch, gelatin). Marginal cost ~$0. Visual or categorical readings; inter-sample ratios at fixed conditions. Not absolute units. Batch-to-batch consistency check; "did this batch ferment to a normal load?"; end-user dosing tied to a Tier 3-calibrated extract ratio.
2. Portable / low-cost quantitative assay Tier 1 plus a phone photometer, portable electrochemical reader, or comparable accessible instrument and its required reagents. Relative or semi-absolute concentration from an analyte- and matrix-specific calibration. Batch tracking or distributed measurement after validation against a Tier 3 method. Smartphone colorimetry is the current common implementation, not the tier definition.
3. Bench Calibrated spectrophotometer, HPLC or comparable, balance, pipettes, qualified analytical standards. Equipment ~$2K capital, ~$200–500 per run. Publication-grade U/mL or mg/g with cited standards and a validated method. Initial calibration per protocol revision; clinical / synergy-experiment-grade data; the ground truth that anchors every Tier 1 and Tier 2 reading.
4. Outsourced Contract lab (GMP / GLP tier). ~$300–1,500 per sample. Audit-trail-grade certified analysis. One-time benchmarking before committing to in-house Tier 3; independent verification of a surprising Tier 3 result; regulatory submission.

The operational pattern: calibrate once, track batches cheap

  1. Initial Tier 3 calibration. Quantify a reference batch by the protocol's validated bench method. Anchor numbers (e.g., mg cordycepin / g extract; U lipase / g koji). Document extract source, batch ID, lot, and harvest conditions.
  2. Batch tracking at Tier 1 or Tier 2. For each new batch from the same protocol, run a cheap assay against the reference batch as the standard curve anchor. If the batch reads within ±20% of reference, accept. If outside, escalate to Tier 3 re-quantification or investigate the deviation.
  3. Experimental sample mass follows the calibrated ratio. Record the lot-specific relationship between material mass and measured compound or activity. This is an experimental input, not a human dose recommendation.
  4. Tier 4 only on demand. Use it when an audit trail, regulatory-grade result, or independent verification is required.

Tier 1 and Tier 2 are optional conveniences, not required links. If no lower-tier method has been validated for the exact analyte, matrix, and decision, measure at Tier 3 directly. Do not substitute a different analyte or matrix merely to preserve a cheap-tracking step.

Why this matters operationally

Tier 3 establishes the reference value; Tier 2 tracks routine batch variation; Tier 1 provides categorical process control. The ladder reduces routine assay cost without pretending that visual or phone-based measurements are equivalent to instrumented analysis.

The ladder also catches a specific class of failure: dose-vs-product-content mismatches. If a commercial extract is marketed at one content level but a Tier 2 colorimetric check shows another, the discrepancy surfaces before downstream therapeutic-dose reasoning depends on the marketed number. See medicinal-mushroom-complement-track.md §"Reality check" for the Real Mushrooms Cordyceps-M case (3–4 mg cordycepin per 1 g serving at 0.4% content, surfaced by tier-discipline thinking).

Optional low-cost automation. Operator variation in serial dilution, mixing, transfer order, and image timing can dominate assay variance. Picolab v2 provides engineering prior art for tube-scale automation using a printer gantry, syringe actuation, G-code planning, camera snapshots, and operator-approved actions. Validate any adaptation first with benign dye and standard-curve work; this is method infrastructure, not evidence that a biological assay is validated.

Instantiations

  • Koji digestive enzyme quantification. enzyme-quantification-protocol.md. Lipase (olive-oil titration → p-NPP smartphone → spectrophotometer p-NPP or pH-stat → outsourced HUT or USP units). Amylase (starch-iodine clearance → DNS reducing-sugar smartphone → bench DNS or Bernfeld → outsourced). Protease (gelatin liquefaction or skim-milk plate → ninhydrin or azocasein smartphone → bench azocasein or pH-stat → outsourced).
  • Medicinal mushroom extract characterization. medicinal-mushroom-extract-sops.md §SOP-6. Cordycepin (visual dosing-by-ratio → speculative diazo Tier 2 pending verification, UV 260 nm fallback → HPLC SOP-2 → outsourced GMP-HPLC). EGT (visual → DTNB Ellman's thiol smartphone → HILIC-HPLC SOP-3 → outsourced). GLPP (visual + mass-balance → phenol-sulfuric total-polysaccharide smartphone → SEC-MALS SOP-1 → outsourced).
  • Microbiome-derived butyrate / SCFA quantification. tier-2-butyrate-assay-audit-computational.md (COMP-038) found no ready-to-adopt Tier 1 or Tier 2 butyrate method for current OE use. HPLC-UV is a Tier 3 bench method, not Tier 2; the De Baere primary abstract reports a method for bacterial culture supernatants, and validation §1.31 tests transfer into an exact OE culture matrix. GC-MS is a Tier 3 comparator when run in-house and Tier 4 when outsourced. Gu et al.'s electrochemical/ANN method is a separate stool-specific Tier 2 candidate whose complete hardware–chemistry–model transfer is staged in validation §1.45.

Class-level measurement gap. Butyrate does not stand in for all microbiome-derived metabolites. Propionate, acetate, secondary bile acids, microbial indoles, and TMAO each require analyte- and matrix-specific validation. Measuring a production input, precursor, culture supernatant, or stool concentration does not establish target-compartment exposure. PMID 23542733 supports the culture-supernatant HPLC-UV method; PMID 42041444 supports a GC-MS-compared electrochemical/ANN method in stool. Neither result transfers automatically to another metabolite or matrix. - Future tracks. TCM compound triage (per tcm-modern-rigor-intersection.md) and siRNA / URAT1 modality (per sirna-urat1-modality.md) inherit the framework as new compound classes are added.

Discipline notes

  • Keep one tier definition. Tier-specific assay details live in the method pages; do not redefine the ladder within each assay.
  • Tier 3 is the calibration anchor for the others. Every Tier 1 and Tier 2 reading needs to translate back to an absolute number, and the only way to get there is through a Tier 3 standard curve. Skipping Tier 3 ("we'll just do Tier 1 forever") collapses inter-sample ratios into vibes.
  • Do not force a lower tier. If the only defensible method is Tier 3, use Tier 3. Relative affordability does not turn HPLC, GC-MS, or another bench analytical method into Tier 2.
  • Tier 4 is not a default escalation. Outsourced assay is for one-time benchmarking or regulatory submission, not routine analysis. The 10× cost gap from Tier 3 to Tier 4 is not value-additive unless you specifically need the audit trail or the GMP chain of custody.
  • The framework is operational quality, not novelty. Adopting it does not require any new science. It requires the discipline to run the calibration step once, log the reference numbers somewhere persistent, and trust the cheap-tier readings against that anchor.

See also